Abstract: A peptide consisting of an amino acid sequence of GPPGPAG (SEQ ID NO: 1) is disclosed. According to the present invention, a novel compound for improving memory disorder is provided.
Type:
Grant
Filed:
August 18, 2017
Date of Patent:
May 26, 2020
Assignees:
JAPAN BIO PRODUCTS Co., Ltd., National University Corporation University of Toyama
Abstract: A peptide consisting of an amino acid sequence of GPPGPAG (SEQ ID NO: 1) is disclosed. According to the present invention, a novel compound for improving memory disorder is provided.
Type:
Application
Filed:
August 18, 2017
Publication date:
November 28, 2019
Applicants:
JAPAN BIO PRODUCTS Co., Ltd., National University Corporation University of Toyama
Abstract: The present invention relates to a hepatocyte-proliferating agent comprising pyroglutamic acid, aspartic acid, and glutamic acid as active ingredients, in particular, a hepatocyte-proliferating agent capable of selectively proliferating normal hepatocytes without proliferating cancer cells.
Abstract: The present invention relates to a medicament for preventing or treating an ocular disease comprising cyclo-trans-4-L-hydroxyprolyl-L-serine as an active ingredient, a medicament for preventing or treating dry eye comprising the compound as an active ingredient, and, in particular, a medicament for preventing or treating dry eye having an action of enhancing mucin secretion and an action of enhancing repair of ocular tissue damage caused by dry eye.
Type:
Grant
Filed:
April 5, 2013
Date of Patent:
January 31, 2017
Assignees:
JAPAN BIO PRODUCTS CO., LTD, THE DOSHISHA
Abstract: The present invention relates to a hepatocyte-proliferating agent comprising pyroglutamic acid, aspartic acid, and glutamic acid as active ingredients, in particular, a hepatocyte-proliferating agent capable of selectively proliferating normal hepatocytes without proliferating cancer cells.